SCHEMBL5346796

SCHEMBL5346796

Cc1cc(Cl)cc(-c2nccs2)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMPD3 Q9NY59 1/20 0.46
ACLY P53396 2/20 0.45
PDPK1 O15530 1/20 0.44
CYP1A1 P04798 3/20 0.40
CYP1A2 P05177 3/20 0.40
CYP1B1 Q16678 3/20 0.40
ADRB2 P07550 1/20 0.40
LOXL2 Q9Y4K0 1/20 0.40
CYP2A6 P11509 1/20 0.40
SRC P12931 3/20 0.39
SYK P43405 3/20 0.39
ZAP70 P43403 2/20 0.39
NPC1 O15118 1/20 0.38
PKM P14618 1/20 0.38
RECQL P46063 1/20 0.38
RAB9A P51151 1/20 0.38
HSD11B1 P28845 1/20 0.37
ADORA2A P29274 2/20 0.35
ADORA1 P30542 2/20 0.35
MET P08581 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10013472 0.87 SMPD3 (0.53) SMPD3PDPK1ADRB2LOXL2CYP2A6
SCHEMBL21930834 0.79 ACLY (0.45) SMPD3ACLYPDPK1CYP1A1CYP1A2
SCHEMBL27398935 0.79 SMPD3 (0.46) SMPD3PDPK1ADRB2LOXL2CYP2A6
SCHEMBL558643 0.75 PDPK1 (0.63) SMPD3PDPK1ADRB2LOXL2CYP2A6
SCHEMBL15668521 0.74 CYP1A1 (0.44) SMPD3CYP1A1CYP1A2CYP1B1ADRB2
SCHEMBL21999853 0.73 ACLY (0.50) SMPD3ACLYPDPK1CYP1A1CYP1A2
Water SCHEMBL20550178 0.73 ADRB2 (0.62) SMPD3PDPK1ADRB2LOXL2CYP2A6
SCHEMBL30579592 0.73 SMPD3 (0.51) SMPD3PDPK1ADRB2LOXL2CYP2A6
SCHEMBL3386179 0.73 CYP2A6 (0.53) SMPD3ACLYPDPK1CYP1A1CYP1A2
SCHEMBL468088 0.73 PDPK1 (0.60) PDPK1CYP1A1CYP1A2CYP1B1LOXL2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1372732-A1 ENZYME-ACTIVATED CYTOSTATIC CONJUGATES WITH INTEGRIN LIGANDS Bayer HealthCare AG (DE) 2004-01-02 EP claimed
WO-2002072151-A1 ENZYME-ACTIVATED CYTOSTATIC CONJUGATES WITH INTEGRIN LIGANDS BAYER AKTIENGESELLSCHAFT (DE) 2002-09-19 WO claimed
US-7220824-B1 Integrin-mediated drug targeting BAYER AKTIENGESELLSCHAFT (DE) 2007-05-22 US disclosed
EP-1347783-A1 CONJUGATES OF INTEGRIN RECEPTOR ANTAGONISTS AND A CYTOSTATIC AGENT HAVING SPECIFICALLY CLEAVABLE LINKING UNITS Bayer Aktiengesellschaft (DE) 2003-10-01 EP disclosed
WO-2002051444-A1 CONJUGATES OF INTEGRIN RECEPTOR ANTAGONISTS AND A CYTOSTATIC AGENT HAVING SPECIFICALLY CLEAVABLE LINKING UNITS BAYER AKTIENGESELLSCHAFT (DE) 2002-07-04 WO disclosed